- Record: found
- Abstract: not found
- Article: not found
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
Yves Le Conte, Philippe Kolh, Paulus Kirchhof, Gregory Y. H. Lip, Bulent Gorenek, Irene Savelieva, , Ottavio Alfieri, Gerhard Hindricks, , Dan Atar, Andreas Goette, Hein Heidbuchel, R. Caterina, Ulrich Schotten, C M Gelder, Frans H Rutten, John Camm, , Bernard Prendergast, Magnus Heldal, P Colonna, Nawwar Al-Attar, Piotr Ponikowski, Sabine Ernst, Johan De Mey, Stefan H Hohloser, Annalisa Angelini
2010-09-30
Acute Coronary Syndrome, epidemiology, therapy, Aged, Angiotensin-Converting Enzyme Inhibitors, therapeutic use, Anti-Arrhythmia Agents, Anticoagulants, Athletes, statistics & numerical data, Atrial Fibrillation, diagnosis, etiology, physiopathology, Cardiomyopathy, Hypertrophic, Comorbidity, Diabetes Mellitus, Electric Countershock, instrumentation, methods, Female, Fibrinolytic Agents, Heart Failure, drug therapy, Heart Rate, drug effects, physiology, Heart Valve Diseases, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hyperthyroidism, Lung Diseases, Male, Middle Aged, Mineralocorticoid Receptor Antagonists, Platelet Aggregation Inhibitors, Pregnancy, Prevalence, Wolff-Parkinson-White Syndrome
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Acute Coronary Syndrome,epidemiology,therapy,Aged,Angiotensin-Converting Enzyme Inhibitors,therapeutic use,Anti-Arrhythmia Agents,Anticoagulants,Athletes,statistics & numerical data,Atrial Fibrillation,diagnosis,etiology,physiopathology,Cardiomyopathy, Hypertrophic,Comorbidity,Diabetes Mellitus,Electric Countershock,instrumentation,methods,Female,Fibrinolytic Agents,Heart Failure,drug therapy,Heart Rate,drug effects,physiology,Heart Valve Diseases,Humans,Hydroxymethylglutaryl-CoA Reductase Inhibitors,Hyperthyroidism,Lung Diseases,Male,Middle Aged,Mineralocorticoid Receptor Antagonists,Platelet Aggregation Inhibitors,Pregnancy,Prevalence,Wolff-Parkinson-White Syndrome
Acute Coronary Syndrome, epidemiology, therapy, Aged, Angiotensin-Converting Enzyme Inhibitors, therapeutic use, Anti-Arrhythmia Agents, Anticoagulants, Athletes, statistics & numerical data, Atrial Fibrillation, diagnosis, etiology, physiopathology, Cardiomyopathy, Hypertrophic, Comorbidity, Diabetes Mellitus, Electric Countershock, instrumentation, methods, Female, Fibrinolytic Agents, Heart Failure, drug therapy, Heart Rate, drug effects, physiology, Heart Valve Diseases, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hyperthyroidism, Lung Diseases, Male, Middle Aged, Mineralocorticoid Receptor Antagonists, Platelet Aggregation Inhibitors, Pregnancy, Prevalence, Wolff-Parkinson-White Syndrome